DualityBio – Talk Bio

Actionable Insights Powered by AI

DualityBio Pursues $200M IPO in Hong Kong Amid Volatile Market Conditions

2 weeks ago talkbio0Tagged Antibody-Drug, BioNTech, biotech sector, DualityBio, global trade tensions, Hong, Immunostimulating conjugate (antigen), Investments, IPO, Kong, Market, Stock exchange, upheaval

DualityBio, IPO, Hong Kong Stock Exchange, biotech investment, antibody-drug conjugates, BioNTech, market upheaval, global trade tensions, biotech sector growth.

GSK Expands Eastern Partnerships with $30M Option on DualityBio’s Preclinical ADC

5 months ago talkbio0Tagged ADC, biotech, DualityBio, pharmaceutical partnerships, Preclinical, SmithKline Beecham, therapeutic autologous dendritic cells

GSK, DualityBio, ADC, Preclinical, Biotech, Pharmaceutical Partnerships